(Q48216581)

English

The long-acting Ca2+-channel blocker azelnidipine prevents left ventricular remodeling after myocardial infarction.

scientific article published on 31 March 2007

Statements

The long-acting Ca2+-channel blocker azelnidipine prevents left ventricular remodeling after myocardial infarction. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit